Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 26.
doi: 10.1002/mds.30273. Online ahead of print.

Evaluation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Siblings with Gaucher Disease Discordant for Parkinsonism

Ellen Hertz  1   2 , Krystyna Rytel  1   2 , Gani Perez  1   2 , Ying Hao  3 , Ziyi Li  3   4 , Charis Ma  1   2 , Kate Andersh  3 , Yue Andy Qi  3 , Emory Ryan  1   2 , Grisel Lopez  1   2 , Nahid Tayebi  1   2 , Ellen Sidransky  1   2 , Yu Chen  1   2
Affiliations

Evaluation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Siblings with Gaucher Disease Discordant for Parkinsonism

Ellen Hertz et al. Mov Disord. .

Abstract

Background: In Gaucher disease (GD), glucocerebrosidase (GCase) deficiency results from biallelic pathogenic GBA1 variants. While GBA1 variants are a major risk factor for Parkinson's disease (PD), most patients with GD never develop parkinsonism.

Objectives: To understand factors impacting PD penetrance in patients with GD by comparing induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DANs) from GD siblings discordant for PD.

Methods: iPSCs, reprogrammed from two different sibling pairs where both siblings had GD but only one developed PD, were differentiated into DANs. In one family, DAN enrichment was achieved via geneticin selection and proteomic evaluations were performed.

Results: GCase and lipid substrate levels were similar in GD and GD/PD DANs. After geneticin selection, proteomic analysis of the enriched DANs showed upregulation of molecular chaperones in the GD/PD line.

Conclusion: PD discordance in both sets of GD siblings did not correlate with GCase or lipid substrate levels in DANs, implicating the involvement of other modifiers. Published 2025. This article is a U.S. Government work and is in the public domain in the USA. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: GBA1; Gaucher disease; Parkinson's disease; dopaminergic neuron differentiation; neurodegeneration.

PubMed Disclaimer

Update of

Similar articles

See all similar articles

References

    1. Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta‐analysis of genome‐wide association studies. Lancet Neurol 2019;18(12):1091–1102.
    1. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009;361(17):1651–1661.
    1. Nalls MA, Duran R, Lopez G, et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol 2013;70(6):727–735.
    1. Anheim M, Elbaz A, Lesage S, et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology 2012;78(6):417–420.
    1. Cilia R, Tunesi S, Marotta G, et al. Survival and dementia in GBA‐associated Parkinson's disease: the mutation matters. Ann Neurol 2016;80(5):662–673.

LinkOut - more resources